Next Article in Journal
Retraction: Carulli, L. et al. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). Metabolites 2019, 9(2), 25
Previous Article in Journal
Drying Enhances Signal Intensities for Global GC–MS Metabolomics
Previous Article in Special Issue
Effects of Early Intervention with Maternal Fecal Microbiota and Antibiotics on the Gut Microbiota and Metabolite Profiles of Piglets
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessArticle

Role of Intestinal Microbiota in Metabolism of Gastrodin In Vitro and In Vivo

College of Pharmacy, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Korea
*
Authors to whom correspondence should be addressed.
Metabolites 2019, 9(4), 69; https://doi.org/10.3390/metabo9040069
Received: 9 March 2019 / Revised: 1 April 2019 / Accepted: 4 April 2019 / Published: 8 April 2019
(This article belongs to the Special Issue Gut Metabolism of Natural Products)
  |  
PDF [1839 KB, uploaded 21 April 2019]
  |  

Abstract

Alteration in the number and composition of intestinal microbiota affects the metabolism of several xenobiotics. Gastrodin, isolated from Gastrodia elata, is prone to be hydrolyzed by intestinal microbiota. In the present study, the role of intestinal microbiota in gastrodin metabolism was investigated in vitro and in vivo. Gastrodin was incubated in an anaerobic condition with intestinal contents prepared from vehicle- and antibiotics-treated rats and the disappearance of gastrodin and formation of 4-hydroxybenzyl alcohol (4-HBA) was measured by liquid chromatography coupled to mass spectroscopy (LC-MS/MS). The results showed that almost all gastrodin incubated with control intestinal contents was metabolized to its aglycone in time- and concentration-dependent manners. In contrast, much less formation of 4-HBA was detected in intestinal contents from antibiotics-treated rats. Subsequently, in vivo pharmacokinetic study revealed that the antibiotic pretreatment of rats significantly affected the metabolism of gastrodin to 4-HBA. When administered orally, gastrodin was rapidly absorbed rapidly into plasma, metabolized to 4-HBA, and disappeared from the body within six hours. Interestingly, the pharmacokinetic parameters of 4-HBA were changed remarkably in antibiotics-treated rats, compared to control rats. The results clearly indicated that the antibiotics treatment of rats suppressed the ability of intestinal microbiota to metabolize gastrodin to 4-HBA and that, thereby, the pharmacodynamic action was significantly modulated. View Full-Text
Keywords: gastrodin; 4-hydroxybenzyl alcohol; antibiotics; intestinal microbiota; metabolism; LC-MS/MS gastrodin; 4-hydroxybenzyl alcohol; antibiotics; intestinal microbiota; metabolism; LC-MS/MS
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Nepal, M.R.; Jeong, K.S.; Kim, G.H.; Cha, D.H.; Kang, M.J.; Kim, J.S.; Kim, J.-H.; Jeong, T.C. Role of Intestinal Microbiota in Metabolism of Gastrodin In Vitro and In Vivo. Metabolites 2019, 9, 69.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top